Status:
COMPLETED
Influence of Rapydan on Clinical Chemistry and Hematology Measurements
Lead Sponsor:
LabNoord
Conditions:
Healthy
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
There is an increasing awareness of the importance of treating procedure-related pain. Patients undergoing vascular access procedures are often afraid of needles and the discomfort associated with inj...
Eligibility Criteria
Inclusion
- Volunteers 20-60 years who are decision making competent
Exclusion
- Patients with local anesthetic allergy Patients using antiarrhythmic drugs Patients using other local anesthetics
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00765934
Start Date
November 1 2009
End Date
May 1 2010
Last Update
May 18 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LabNoord
Groningen, Provincie Groningen, Netherlands